Volume 30, Issue 110 (February 2018)
IJN 2018, 30(110): 45-57 |
Back to browse issues page
1- Professor, PhD of Nursing, Nursing Care Research Center, Iran University of Medical Sciences, Tehran, Iran
2- PhD of Clinical Psychology, Psychiatry and Psychology Research Center, Tehran University of Medical Sciences, Tehran, Iran. (Corresponding Author). Tel: 021554022002 E-mail:alavi@sdlrc.mui.ac.ir
3- Ms of Psychology, Kerman University of Medical Sciences, Kerman, Iran
2- PhD of Clinical Psychology, Psychiatry and Psychology Research Center, Tehran University of Medical Sciences, Tehran, Iran. (Corresponding Author). Tel: 021554022002 E-mail:alavi@sdlrc.mui.ac.ir
3- Ms of Psychology, Kerman University of Medical Sciences, Kerman, Iran
Abstract: (5461 Views)
Abstract
Background & Aims: Today, the role of non-drug treatment is important in the treatment of addiction. Compliance therapy plays effective role in improvement of quality of life, reducing the effects sides of treatment and especially in mental health promotion. The present study has been designed to determine the effect of “compliance therapy “with group therapy on quality of life, general function, acceptance and care after illness in opioid addicted under Methadone Meintanance Therapy (MMT).
Material & Method: The clinical trial methodology was done on the addicted persons who are in recovery phase, in 4 addiction treatment centers in Tehran city during 2016 year. Initially, 120 patients were selected randomly, they were devided in four groups (group therapy, group therapy and compliance therapy, compliance therapy and control group). The variables of study were quality of life (QOL), Global Function, treatment acceptance, this variables were assessed by Quality of Life Questionnaire, and Global Assessment Function and compliance therapy scale. To data analysis we used descriptive and inferential statistic (ANOVA) and ANCOVA via SPSS 20 software.
Results: Based on ANOVA analysis, there are significant differences in sub scales of quality of life questionnaire (including interpersonal relationship, activities and Common goals), Global Function Assessment in Social, vocational and educational fields and score of compliance between 4 groups. (P-value<0.05), But there isn’t significant differences in “personality foundation” and “role effectiveness’ between 4 groups.
Conclusion: The results showed that, care after treatment such as group therapy, compliance therapy or matrix therapy are effectiveness in treatment of addiction.
Background & Aims: Today, the role of non-drug treatment is important in the treatment of addiction. Compliance therapy plays effective role in improvement of quality of life, reducing the effects sides of treatment and especially in mental health promotion. The present study has been designed to determine the effect of “compliance therapy “with group therapy on quality of life, general function, acceptance and care after illness in opioid addicted under Methadone Meintanance Therapy (MMT).
Material & Method: The clinical trial methodology was done on the addicted persons who are in recovery phase, in 4 addiction treatment centers in Tehran city during 2016 year. Initially, 120 patients were selected randomly, they were devided in four groups (group therapy, group therapy and compliance therapy, compliance therapy and control group). The variables of study were quality of life (QOL), Global Function, treatment acceptance, this variables were assessed by Quality of Life Questionnaire, and Global Assessment Function and compliance therapy scale. To data analysis we used descriptive and inferential statistic (ANOVA) and ANCOVA via SPSS 20 software.
Results: Based on ANOVA analysis, there are significant differences in sub scales of quality of life questionnaire (including interpersonal relationship, activities and Common goals), Global Function Assessment in Social, vocational and educational fields and score of compliance between 4 groups. (P-value<0.05), But there isn’t significant differences in “personality foundation” and “role effectiveness’ between 4 groups.
Conclusion: The results showed that, care after treatment such as group therapy, compliance therapy or matrix therapy are effectiveness in treatment of addiction.
Received: 2017/11/14 | Accepted: 2018/02/12 | Published: 2018/02/12
References
1. UNODC in Islamic Republic of Iran 2017.Available at : https://www.unodc.org/islamicrepublicofiran/fa/world-drug-report-2017_-29-5-million-people-globally-suffer-from-drug-use-disorders--opioids-the-most-harmful-fa.html
2. Aliverdinia A, Rezaie A, Peiro F. [A sociological analysis of University students attitude's toward suicide]. Applied Sociology.2012;22(4):1-18.
3. Sarami H, Ghorbani M, Minoie M. [Four decades of research on the prevalence of drug abuse in Iran]. Quarterly Journal of Research on Addiction. 2013;7(26):29-52.
4. Tabebordbar F. [Meta-Analysis of Effectiveness of Cbt Treatment on Addiction and General Health of Addicted]. Methods and Models in Psychology. 2014;3(14): 1-11.
5. Najarzadegan M, Tavalaee A. [A Prevention Survey about the Treatment Protocols For the Substance Abuse In War Injured Soldiers]. Ann Mil Health Sci Res. 2012;10(2):163-73.
6. Zemestani M, Babamiri M, Sepyani A. [On the Effectiveness of Mindfulness-Based Relapse Prevention in Substance Abuse and the Severity of Comorbidity of Depression and Anxiety Symptoms in the Addicts of Therapeutic Community Centers] .Journal of research on addiction. Presidential Drug Control Headquarters. 2016;10(39): 179-94.
7. Mahmoodi Gh, Amiri M, Jahani MA, Hajibagloo E. [A Survey on the Mental Health and Quality of Life of Addicts Referring to Methadone Therapy in Sari, 2012]. Health management (health system). 2011;3(3-4): 7-17.
8. Moradi A. [Evaluation of the Effect of Methadone Maintenance Therapy (MMT) on Reducing Injury in Male client, Hamadan Central Prison, 2009]. The Journal of Toloo-e-behdasht (Shahid Sadoughi University of Medical Sciences).2010;8(3-4): 3.
9. Ghorbani T, Mohammadkhni S, Sarami G. [The comparison of the effectiveness of group cognitive-behavior therapy and methadone maintenance therapy on changing beliefs related to substance and relapse prevention]. Research on Addiction. 2012;6(22):23-38.
10. Vornganti LP. Medications and Quality of life. Psychiatric times. 2008;25(5):1-2.
11. Sadock BJ, Sadock VA, Ruiz P. Comprehensive textbook of psychiatry. Philadelphia; Williams and Wilkins. 2017.
12. Beygi A, Farahani M, Mohammadkhani S, Mohammadifar MA. [The Discriminative Role of Quality of Life and Hope in Narcotic Anonymous and Methadone Maintenance Groups]. Journal of clinical psychology.2011;3(3) : 75-84.
13. Jannesari Z, Omranifard V, Maracy MR, Soltani S. [The effect of compliance therapy on quality of life and global function of schizophrenic patients]. Journal of Behavioral Sciences. 2011;9(2):114-22.
14. Maneesakorn S, Robson D, Gournay K, Gray R. An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand. J Clin Nurs. 2007;16(7):1302-12. [DOI:10.1111/j.1365-2702.2007.01786.x] [PMID]
15. Sadock BJ, Sadock VA. Textbook of Psychiatry(chapter 1). Shahrab Publication. 2008.
16. Hilsenroth MJ, Ackerman SJ, Blagys MD, Baumann BD, Baity MR, Smith SR, et al. Reliability and validity of DSM-IV axis V. Am J Psychiatry. 2000;157(11):1858-63. [DOI:10.1176/appi.ajp.157.11.1858] [PMID]
17. Kalateh-jari M, Bagheri H, Hassani M. [The effect of aerobic exercise program on quality of life in schizophrenic patients]. Journal of Shahrekord Uuniversity of Medical Sciences. 2007;9(3):28-36.
18. O'donnell C, Donohoe G, Sharkey L, Owens N, Migone M, Harries R, et al. Compliance therapy: a randomised controlled trial in schizophrenia. BMJ. 2003;327(7419):834. [DOI:10.1136/bmj.327.7419.834] [PMID] [PMCID]
19. Gholamaliei B, Karimi-Shahanjarini A, Roshanaei G, Rezapour-Shahkolaei F. [Medication Adherence and its Related Factors in Patients with Type II Diabetes]. J Educ Community Health. 2016;2(4):3-12. [DOI:10.21859/jech-02042]
20. Association AP. Diagnostic and statistical manual of mental disorders: (DSM-5), 5th ed. Washington DC: American Psychiatric Association; 2013. [DOI:10.1176/appi.books.9780890425596]
21. Cramer P. Protecting the self: Defense mechanisms in action: Guilford Press; 2006.
22. Rouget BW, Aubry J-M. Efficacy of psychoeducational approaches on bipolar disorders: a review of the literature. J Affect Disord. 2007;98(1):11-27. [DOI:10.1016/j.jad.2006.07.016] [PMID]
23. Miklowitz DJ. Family treatment for bipolar disorder and substance abuse in late adolescence. J Clin Psychol. 2012;68(5):502-13. [DOI:10.1002/jclp.21855] [PMID] [PMCID]
24. Safari H, Miladi Gorji H. [Anxiety-like behavior profile in morphine dependent rats exposed to acute and chronic stress]. Tehran University Medical Journal. 2013:709-16.
25. Quaglio G, Lugoboni F, Pattaro C, Melara B, Mezzelani P, Des Jarlais DC. Erectile dysfunction in male heroin users, receiving methadone and buprenorphine maintenance treatment. Drug Alcohol Depend. 2008;94(1):12-8. [DOI:10.1016/j.drugalcdep.2007.09.025] [PMID]
26. Zhang H-S, Xu Y-M, Zhu J-H, Zhong B-L. Poor sleep quality is significantly associated with low sexual satisfaction in Chinese methadone-maintained patients. Medicine. 2017;96(39). [DOI:10.1097/MD.0000000000008214]
27. Bang‐Ping J. Sexual dysfunction in men who abuse illicit drugs: a preliminary report. J Sex Med. 2009;6(4):1072-80. [DOI:10.1111/j.1743-6109.2007.00707.x] [PMID]
28. Hallinan R, Byrne A, Agho K, McMahon C, Tynan P, Attia J. Erectile dysfunction in men receiving methadone and buprenorphine maintenance treatment. J Sex Med. 2008;5(3):684-92. [DOI:10.1111/j.1743-6109.2007.00702.x] [PMID]
29. Lari MA, Faramarzi H, Shams M, Marzban M, Joulaei H. [Sexual dysfunction, depression and quality of life in patients with HIV infection]. Iranian journal of psychiatry and behavioral sciences. 2013;7(1):61.
30. Salimi M. [Substance abuse and mental illness]. Social Health & Addiction, 2015;1(2) : .29-40.
31. Tay S-EC. Compliance therapy: an intervention to improve inpatients' attitudes toward treatment. J Psychosoc Nurs Ment Health Serv. 2007;45(6):29-37. [PMID]
32. Farnam A .[The Effect of Positive Thinking Training in Enhancement of Quality and Hope of life among the Elderly]. Positive Psychology.2016;2(1): 75-88.
33. Alavi SS, Ferdosi M, Jannatifard F, Eslami M, Alaghemandan H, Setare M. Behavioral addiction versus substance addiction: Correspondence of psychiatric and psychological views. Int J Prev Med. 2012;3(4):290. [PMID] [PMCID]
34. Kimonis ER, Frick PJ. Oppositional defiant disorder and conduct disorder grown-up. J Dev Behav Pediatr. 2010;31(3):244-54. [DOI:10.1097/DBP.0b013e3181d3d320] [PMID]
35. Buitelaar JK, Smeets KC, Herpers P, Scheepers F, Glennon J, Rommelse NN. Conduct disorders. Eur Child Adolesc Psychiatry. 2013;22(1):49-54. [DOI:10.1007/s00787-012-0361-y] [PMID]
36. Alavi SS, Jannatifard F, Maracy MR, Alaghemandan H, Setare M. Comparison of national and personal identity between person with internet addiction disorder and normal internet users. Journal of education and health promotion. 2014;3.
37. Dulcan M. Dulcan's Textbook of Child and Adolescent Psychiatry: American Psychiatric Pub; 2010.
38. Alavi SS, Jannatifard F, Eslami M, Rezapour H. [Evaluation of diagnostic criteria of DSM-IV-TR for diagnosis of internet addiction disorder]. ZJRMS. 2011; 13 (6) :31-5
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |